Pressure Biosciences Inc PBIO:OTCQB

RT Quote | Exchange | USD
Last | 02/26/21 EST
2.30quote price arrow down-0.19 (-7.63%)
Volume
10,518
52 week range
1.19 - 4.49

...

Loading . . .

KEY STATS

  • Open2.35
  • Day High2.49
  • Day Low2.06
  • Prev Close2.49
  • 52 Week High4.49
  • 52 Week High Date05/05/20
  • 52 Week Low1.19
  • 52 Week Low Date03/16/20
  • Market Cap8.92M
  • Shares Out3.88M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • 1 Year % Change24.32

RATIOS/PROFITABILITY

  • EPS (TTM)-6.09
  • P/E (TTM)-0.38
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-5.326M
  • ROE (MRQ)-
  • Revenue (MRQ)1.34M
  • Gross Margin (MRQ)36.04%
  • Net Margin (MRQ)-1,159.11%
  • Debt To Equity (MRQ)-59.26%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Pressure Biosciences Inc News

There is no recent news for this security.

Latest PBIO News From Our Partners

QUOTE FINDER

Profile

MORE
Pressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The Company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological...
Jeffery Peterson
Chairman
Daniel Shea
Chief Financial Officer
Address
14 Norfolk Ave
South Easton, MA
02375-1907
United States